In the previous section, we have substantially introduced the potential therapeutic targets of the IFN-γ/STAT1 pathway in gastrointestinal tumors, as well as the molecules and medicines that may have therapeutic effects against different targets. The gene discussed is IFNG; the disease is digestive system neoplasm.